JP2005224653A - Method for crystallizing protein - Google Patents

Method for crystallizing protein Download PDF

Info

Publication number
JP2005224653A
JP2005224653A JP2004033095A JP2004033095A JP2005224653A JP 2005224653 A JP2005224653 A JP 2005224653A JP 2004033095 A JP2004033095 A JP 2004033095A JP 2004033095 A JP2004033095 A JP 2004033095A JP 2005224653 A JP2005224653 A JP 2005224653A
Authority
JP
Japan
Prior art keywords
protein
containing sample
crystallization
agent
crystallizing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004033095A
Other languages
Japanese (ja)
Inventor
Nozomi Shibuya
望 渋谷
Isao Tanaka
勲 田中
Nobuhisa Watanabe
信久 渡邉
Chiharu Nishijima
千晴 西嶋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Rayon Co Ltd
Original Assignee
Mitsubishi Rayon Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Rayon Co Ltd filed Critical Mitsubishi Rayon Co Ltd
Priority to JP2004033095A priority Critical patent/JP2005224653A/en
Publication of JP2005224653A publication Critical patent/JP2005224653A/en
Pending legal-status Critical Current

Links

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method for crystallizing a protein, by which a high-quality protein crystal suitable for X-ray analysis, or the like, can be obtained. <P>SOLUTION: This method for crystallizing the protein comprises a step (a) of adding a protein-containing sample to a gelated polymer keeping a protein crystallizing agent to make a protein solution formed by adding the protein-containing sample contact with the protein crystallizing agent and a step (b) of furthermore stratifying an oil phase on the protein-containing sample. The protein crystallizing agent is migrated slowly to the portion of the protein-containing sample from the gelated polymer and the protein-containing sample is migrated slowly to the gelated polymer keeping the protein crystallizing agent to cause a crystallization reaction little by little. Simultaneously, moisture is migrated to the oil phase to concentrate the protein solution gradually. Since the interaction, which is a crystallizing mechanism, between the protein and the surrounding environment (such as the presence of the protein crystallizing agent, the protein concentration and the pH) is advanced gradually by these two effects from two directions, the generation of a high-quality crystal nucleus can be promoted in a short time and the high-quality protein crystal can be obtained. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

本発明は蛋白質含有試料から蛋白質の結晶を析出させる方法に関する。   The present invention relates to a method for precipitating protein crystals from a protein-containing sample.

近年、蛋白質の構造を網羅的に解析し、それに基づいて生命現象の仕組みを探索しようとするいわゆる構造ゲノム科学と呼ばれる動きが活発化している。構造ゲノム科学においては、構造解析の過程をさらに省力化及びスピードアップする必要があり、そのためにはより微量の蛋白質試料を用いて、迅速且つ効率的に結晶化条件をスクリーニングする方法の開発が望まれている。   In recent years, a so-called structural genomics science has been activated to comprehensively analyze protein structures and to search for the mechanism of life phenomena based on the analysis. In structural genomics, it is necessary to further save labor and speed up the structural analysis process. To this end, it is hoped to develop a method for screening crystallization conditions quickly and efficiently using a smaller amount of protein sample. It is rare.

蛋白質の立体構造解析を行うにはその良好な結晶が必要とされ、それを調製するための条件の探索には多量の試料と長時間を費やすことが現在の課題となっている。すなわち、既存の方法では非常に煩雑な操作を必要として非効率的であるとともに多くの蛋白質試料が必要であった。   In order to analyze a three-dimensional structure of a protein, a good crystal is required, and a large amount of sample and a long time are currently a subject for searching for conditions for preparing the protein. That is, the existing methods require very complicated operations and are inefficient and require many protein samples.

この目的で結晶化スクリーニング試薬キットの開発が行われており、結晶化条件のスクリーニングに必要なスクリーニング試薬の調製時間に関する条件は改善されてきている。例えば、固体支持体に複数の種類の蛋白質結晶化剤を固定してなる蛋白質結晶化スクリーニング用固定化試薬が提案されている(特許文献1)。しかし、これも含めて従来の結晶化条件のスクリーニングは一条件あたり数マイクロリットルの溶液量で行われており、結晶化条件の探索時間は数時間から数日に及ぶ。このため更なる試料の微量化及び結晶化条件の探索時間の短縮が望まれている。   For this purpose, crystallization screening reagent kits have been developed, and conditions related to the preparation time of screening reagents necessary for screening crystallization conditions have been improved. For example, an immobilization reagent for protein crystallization screening in which a plurality of types of protein crystallization agents are immobilized on a solid support has been proposed (Patent Document 1). However, the screening of the conventional crystallization conditions including this is performed with a solution amount of several microliters per condition, and the search time for the crystallization conditions ranges from several hours to several days. For this reason, further miniaturization of the sample and shortening of the search time for the crystallization conditions are desired.

一方、上記の背景から蛋白質結晶化方法として種々の手法が提案されている。例えば、バッチ法、蒸気拡散法及び液-液拡散法(又は透析法)が挙げられる。   On the other hand, various methods have been proposed as protein crystallization methods from the above background. Examples thereof include a batch method, a vapor diffusion method, and a liquid-liquid diffusion method (or dialysis method).

「バッチ法」は蛋白質溶液に結晶化剤を含む溶液を少しずつ加え、わずかに濁ったところで不溶物を遠心分離して除去し、上清を小さな試験管等に入れて密封した後、静置する方法である。この方法は、操作は簡便であるが結晶が得られにくい。さらには結晶の品質が良好ではないという問題点がある。また結晶化条件を能動的に制御する必要がある。   In the “batch method”, a solution containing a crystallization agent is added little by little to a protein solution, and insoluble matters are removed by centrifugation in a slightly cloudy state. The supernatant is placed in a small test tube and sealed, and then allowed to stand. It is a method to do. Although this method is simple in operation, it is difficult to obtain crystals. Furthermore, there is a problem that the quality of the crystal is not good. It is also necessary to actively control the crystallization conditions.

「蒸気拡散法」は蛋白質結晶化剤を含む蛋白質溶液の液滴を、より高濃度の結晶化剤を含む緩衝液(外部)の入った容器中に置き、密閉後、静置する方法である。液滴の置き方によりハンギングドロップ法、シッティングドロップ法に区別される。ハンギングドロップ法とは、蛋白質溶液の小さな液滴をカバーガラス上に設置し、カバーガラスを溶液溜め上で反転させ、密閉する方法である。シッティングドロップ法とは溶液溜め内部に液滴台を設置し、蛋白質溶液の小滴を液滴台上に設置し、カバーガラス等で液滴溜めを密閉する方法である。蒸気拡散法では、蛋白質溶液及び結晶化剤の濃度が時間と共に変化する。また使用する蛋白量が少量ですむため、幅広い結晶化条件のスクリーニングに使用されている(特許文献2)。蒸気拡散法は多数の条件をより微量の蛋白質で検討できるが、その際、高価な装置が必要となる。   “Vapor diffusion method” is a method in which a droplet of a protein solution containing a protein crystallization agent is placed in a container containing a buffer solution (external) containing a higher concentration crystallization agent, and then left to stand after sealing. . A distinction is made between the hanging drop method and the sitting drop method, depending on how the droplets are placed. The hanging drop method is a method in which a small droplet of a protein solution is placed on a cover glass, the cover glass is inverted on the solution reservoir, and sealed. The sitting drop method is a method in which a droplet base is placed inside a solution reservoir, a small drop of protein solution is placed on the droplet reservoir, and the droplet reservoir is sealed with a cover glass or the like. In the vapor diffusion method, the concentration of the protein solution and the crystallization agent changes with time. Further, since a small amount of protein is used, it is used for screening of a wide range of crystallization conditions (Patent Document 2). In the vapor diffusion method, a large number of conditions can be examined with a smaller amount of protein, but in that case, an expensive apparatus is required.

「液-液拡散法」又は「透析法」は、蛋白質溶液を結晶化剤の入った緩衝液に対して、それぞれ両溶液の界面もしくはゲル又は半透膜を境界として接触させ、蛋白質溶液中の結晶化剤の濃度を徐序に上昇させる方法である。これらの方法は蒸気拡散法及びバッチ法の利点を有し、良質な蛋白質結晶を得るために好適である。しかし、これらの方法は比較的多量の蛋白質溶液を使用し、蛋白質溶液の液量を少量化することも困難である。また操作は煩雑で時間がかかるため、簡便とは言いがたい。   “Liquid-liquid diffusion method” or “dialysis method” is a method in which a protein solution is brought into contact with a buffer solution containing a crystallization agent at the interface of both solutions or a gel or a semipermeable membrane, respectively. In this method, the concentration of the crystallization agent is gradually increased. These methods have the advantages of the vapor diffusion method and the batch method, and are suitable for obtaining high-quality protein crystals. However, these methods use a relatively large amount of protein solution, and it is difficult to reduce the amount of the protein solution. Also, since the operation is complicated and time consuming, it is difficult to say that it is simple.

また本発明者は上記の背景技術を踏まえて、蛋白質含有試料を、蛋白質結晶化剤を保持するゲルポリマーに供し、前記蛋白質溶液と結晶化剤を接触させる方法によりX線結晶構造解析に適した蛋白質の結晶を簡便に取得する方法を提案している。   In addition, based on the above background art, the present inventor used a protein-containing sample for a gel polymer holding a protein crystallization agent, and was suitable for X-ray crystal structure analysis by contacting the protein solution with the crystallization agent. A method for easily obtaining protein crystals has been proposed.

しかし、上記の方法は、結晶をゆっくりと成長させる点においては優れているが、適当な核を発生させるには温度、圧力等の多数のエネルギー変化(熱ゆらぎ)が必要となる。よって有利な方法とは言いがたい部分もある。
特開平9−89898 WO00/60345
However, the above method is excellent in that the crystal grows slowly, but a large number of energy changes (thermal fluctuations) such as temperature and pressure are required to generate appropriate nuclei. Therefore, there are some parts that are difficult to say.
JP-A-9-89898 WO00 / 60345

本発明者らは、上記の問題点を解決するため鋭意検討を行った結果、蛋白質を結晶化させるための方法において、蛋白質含有試料を、蛋白質結晶化剤を保持するゲルポリマーに供し、前記蛋白質溶液と結晶化剤を接触させる工程に加え、蛋白質含有試料に油相を重層する工程を付加することにより、短時間で良質な核発生を促し、さらにはX線結晶構造解析に適した蛋白質の結晶を簡便に取得することができることを見出し、本発明を完成させた。   As a result of intensive studies to solve the above problems, the present inventors have provided a protein-containing sample to a gel polymer holding a protein crystallization agent in a method for crystallizing a protein, and the protein In addition to the step of bringing the solution into contact with the crystallization agent, the addition of a step of layering the oil phase on the protein-containing sample promotes the generation of high-quality nuclei in a short time, and further, the protein suitable for X-ray crystal structure analysis The inventors have found that crystals can be easily obtained, and have completed the present invention.

すなわち、本発明は、
蛋白質を結晶化させるための方法において、以下の工程を含むことを特徴とする蛋白質結晶化方法である。
That is, the present invention
A method for crystallizing a protein is a method for crystallizing a protein, comprising the following steps.

(a)蛋白質含有試料を、蛋白質結晶化剤を保持するゲルポリマーに供し、前記蛋白質溶液と結晶化剤を接触させる工程。 (a) A step of subjecting the protein-containing sample to a gel polymer holding a protein crystallization agent and bringing the protein solution into contact with the crystallization agent.

(b)さらに蛋白質含有試料に油相を重層する工程。 (b) A step of overlaying an oil phase on the protein-containing sample.

本発明によれば、蛋白質結晶化剤がゲル中から蛋白質含有試料の部分に、又は蛋白質含有試料が蛋白質結晶化剤を保持するゲル中に、ゆっくりと移行し、結晶化反応も少しずつ起こる。それと同時に油相に水分が移行し、蛋白質溶液が徐序に濃縮される。この2つの効果により、結晶化のメカニズムである、蛋白質と周囲環境(蛋白質結晶化剤の存在、蛋白質濃度、pH等)との相互作用が徐々に2方向から進行するため、短時間で良質な核発生を促し、良質な結晶を取得することができる。   According to the present invention, the protein crystallization agent slowly moves from the gel into the protein-containing sample portion, or the protein-containing sample slowly moves into the gel holding the protein crystallization agent, and the crystallization reaction occurs little by little. At the same time, water moves to the oil phase and the protein solution is gradually concentrated. Because of these two effects, the interaction between the protein and the surrounding environment (presence of protein crystallization agent, protein concentration, pH, etc.), which is the mechanism of crystallization, gradually proceeds from two directions, so that the quality is improved in a short time. Nucleation is promoted and high quality crystals can be obtained.

本明細書中で使用される「蛋白質」という用語は、天然又は合成のペプチド、ポリペプチド、蛋白質及び蛋白質複合体を包含する。これらの物質は、天然若しくは合成材料から抽出・単離、又は遺伝子工学的手法若しくは化学合成手法等により生成した後、通常の精製法、例えば溶媒抽出、カラムクロマトグラフィー、液体クロマトグラフィーなどを組み合わせて用いることにより精製することができる。   The term “protein” as used herein includes natural or synthetic peptides, polypeptides, proteins and protein complexes. These substances are extracted and isolated from natural or synthetic materials, or produced by genetic engineering techniques or chemical synthesis techniques, and then combined with conventional purification methods such as solvent extraction, column chromatography, liquid chromatography, etc. It can be purified by use.

本明細書中で使用される「結晶化」という用語は、蛋白質溶液から結晶を成長又は析出させて結晶を得ることを指す。   The term “crystallization” as used herein refers to obtaining crystals by growing or precipitating crystals from a protein solution.

本明細書中で使用される「蛋白質含有試料」という用語は、結晶化対象の蛋白質、又は結晶化条件を特定しようとする対象の蛋白質を含む試料を指す。   As used herein, the term “protein-containing sample” refers to a sample containing a protein to be crystallized or a protein to be crystallized for which crystallization conditions are to be specified.

本明細書中で使用される「蛋白質結晶化剤」という用語は、蛋白質の溶解度を下げる働きをする化合物を意味し、沈殿剤、pH緩衝剤、その他附加物等が挙げられる。   As used herein, the term “protein crystallizing agent” means a compound that acts to lower the solubility of a protein, and includes a precipitating agent, a pH buffering agent, and other additives.

本明細書中で使用される「ポリマーゲル」という用語は、重合性モノマー若しくはその溶液を、重合反応によりポリマー化若しくはゲル化させたもの、あるいは、合成ポリマーや天然ポリマーの添加により溶液の流動性をなくしたものを意味する。   As used herein, the term “polymer gel” refers to a polymerized monomer or solution thereof that has been polymerized or gelated by a polymerization reaction, or the fluidity of a solution by the addition of a synthetic polymer or a natural polymer. It means the thing which lost.

本発明は、蛋白質を結晶化させるための方法において、以下の工程を含むことを特徴とする蛋白質結晶化方法である。   The present invention is a protein crystallization method characterized by including the following steps in a method for crystallizing a protein.

(a) 蛋白質含有試料を、蛋白質結晶化剤を保持するゲルポリマーに供し、前記蛋白質溶液と結晶化剤を接触させる工程。 (a) A step of subjecting the protein-containing sample to a gel polymer holding a protein crystallization agent and bringing the protein solution into contact with the crystallization agent.

(b) さらに蛋白質含有試料に油相を重層する工程。 (b) A step of overlaying an oil phase on the protein-containing sample.

蛋白質の結晶化には、種々の相互作用が複雑に影響を及ぼしている。本発明は、このような種々の相互作用が徐々にゆっくりと変更するために、ゲルにおける拡散現象を利用して蛋白質と蛋白質結晶化剤とをゆっくりと接触させ、それらの間の相互作用及びその他の相互作用を徐々に変更した状態を作り出す。さらに、蛋白質含有試料に油相を重層することにより、油相部に蛋白質溶液の水分が移動し、蛋白質溶液が濃縮される。その結果、本蛋白質結晶化方法により、短時間で良質な核発生を促し、良好な品質の蛋白質結晶を簡便かつ高効率に析出することができる。   Various interactions have a complex influence on protein crystallization. In order to gradually and slowly change these various interactions, the present invention uses a diffusion phenomenon in a gel to slowly bring a protein into contact with a protein crystallizing agent, the interaction between them and others. Create a state that gradually changes the interaction. Furthermore, by layering the oil phase on the protein-containing sample, the moisture of the protein solution moves to the oil phase portion, and the protein solution is concentrated. As a result, the present protein crystallization method can promote the generation of high-quality nuclei in a short time, and can precipitate a high-quality protein crystal simply and efficiently.

本蛋白質結晶化方法の工程(a)では、蛋白質含有試料を、蛋白質結晶化剤を保持するポリマーゲルに供する。ここで、蛋白質含有試料は、結晶化対象の蛋白質の他、さらに、蛋白質の溶解を助ける蛋白質可溶化剤、還元剤等の安定化剤などを含有してもよい。蛋白質可溶化剤としては、例えば膜蛋白質を溶解させる界面活性剤などを例示することができる。またここで、蛋白質結晶化剤を保持するポリマーゲルは、以下のように調製することができる。   In step (a) of the present protein crystallization method, the protein-containing sample is subjected to a polymer gel holding a protein crystallization agent. Here, the protein-containing sample may further contain a protein solubilizing agent that helps dissolve the protein, a stabilizing agent such as a reducing agent, in addition to the protein to be crystallized. Examples of protein solubilizers include surfactants that dissolve membrane proteins. Here, the polymer gel holding the protein crystallizing agent can be prepared as follows.

本発明に用いることができるポリマーゲルの種類は特に制限されないが、例えばアクリルアミド、N,N−ジメチルアクリルアミド、N−イソプロピルアクリルアミド、N−アクリロイルアミノエトキシエタノール、N−アクリロイルアミノプロパノール、N−メチロールアクリルアミド、N−ビニルピロリドン、ヒドロキシエチルメタクリレート、(メタ)アクリル酸、アリルデキストリン等の単量体の一種類又は二種類以上と、メチレンビス(メタ)アクリルアミド、ポリエチレングリコールジ(メタ)アクリレート等との多官能性単量体を、例えば水性媒体中で共重合したゲルを用いることができる。その他本発明に用いることのできるポリマーゲルとして、例えばアガロース、アルギン酸、デキストラン、ポリビニルアルコール、ポリエチレングリコール等のゲル、又はこれらを架橋したゲルを用いることができる。   The type of polymer gel that can be used in the present invention is not particularly limited. For example, acrylamide, N, N-dimethylacrylamide, N-isopropylacrylamide, N-acryloylaminoethoxyethanol, N-acryloylaminopropanol, N-methylolacrylamide, Multi-functionality of one or more monomers such as N-vinylpyrrolidone, hydroxyethyl methacrylate, (meth) acrylic acid, allyl dextrin and methylene bis (meth) acrylamide, polyethylene glycol di (meth) acrylate, etc. For example, a gel obtained by copolymerizing monomers in an aqueous medium can be used. Other polymer gels that can be used in the present invention include, for example, gels such as agarose, alginic acid, dextran, polyvinyl alcohol, and polyethylene glycol, or gels obtained by crosslinking these.

任意の容器(例えばマイクロアレイ)にゲルを充填するには、ゲル構成成分であるアクリルアミド等の単量体、多官能性単量体及び開始剤を含む液を該容器に注入し、重合、ゲル化させればよい。ゲル化は多官能性単量体の存在下に共重合させる方法の他、多官能性単量体の非存在下に共重合させたのち架橋剤を用いて行ってもよい。またアガロースゲルの場合には温度降下によってゲル化を行ってもよい。   In order to fill a gel in an arbitrary container (for example, a microarray), a liquid containing a monomer such as acrylamide as a gel component, a polyfunctional monomer, and an initiator is injected into the container, and polymerization and gelation are performed. You can do it. Gelation may be carried out using a crosslinking agent after copolymerization in the absence of a polyfunctional monomer, in addition to a method of copolymerization in the presence of a polyfunctional monomer. In the case of an agarose gel, gelation may be performed by a temperature drop.

蛋白質結晶化剤をポリマーゲルに保持させるための方法は、特に制限されるものではない。ここで「保持」とは、蛋白質結晶化剤をポリマーゲルに固定化することを意味する。例えば、蛋白質結晶化剤と上記重合性モノマーを混合して予め適当な容器に導入しておき、その後、重合過程を経てポリマーゲルを形成させて蛋白質結晶化剤を固定化することができる。ポリマーゲルに保持させる蛋白質結晶化剤は、結晶化対象の蛋白質の種類及び濃度などにより異なるが、当業者であれば適切な蛋白質結晶化剤を選択し、適宜その濃度及び量を設定して、ポリマーゲルに保持させることができる。   The method for retaining the protein crystallizing agent on the polymer gel is not particularly limited. Here, “retaining” means immobilizing the protein crystallizing agent on the polymer gel. For example, the protein crystallization agent and the polymerizable monomer can be mixed and introduced in advance into an appropriate container, and then a polymer gel can be formed through a polymerization process to immobilize the protein crystallization agent. The protein crystallization agent to be retained in the polymer gel varies depending on the type and concentration of the protein to be crystallized, but those skilled in the art will select an appropriate protein crystallization agent, set the concentration and amount appropriately, It can be held on a polymer gel.

あるいは、蛋白質結晶化剤を多孔性粒子などに含浸させ、その粒子をポリマーゲルに包括させることも可能である。   Alternatively, it is possible to impregnate a porous particle or the like with a protein crystallizing agent and include the particle in a polymer gel.

蛋白質結晶化剤としては、例えばGrid ScreenTM、Crystal ScreenTM I & II、WizardTM I & II等の市販されているものと同様の条件を使用することができる。 As the protein crystallizing agent, for example, conditions similar to those commercially available such as Grid Screen , Crystal Screen I & II, Wizard I & II can be used.

ここで、結晶化の様子が顕微鏡等で経時的に観察可能とするために、蛋白質結晶化剤を保持するポリマーゲルは、透明であることが好ましい。「透明」とは、必ずしも光の透過率が100%であることを意味せず、結晶化の様子が観察できる程度に透明であればよい。   Here, the polymer gel holding the protein crystallization agent is preferably transparent so that the state of crystallization can be observed over time with a microscope or the like. The term “transparent” does not necessarily mean that the light transmittance is 100%, and it is sufficient that the crystallinity can be observed.

例えば、NaClをゲル中に保持させる場合には、該ゲルは、アクリルアミド、2−アクリルアミド−2−メチルプロパンスルホン酸、メタクリル酸ジメチルアミノメチルクロライド塩から作製されることが好ましい。その他、蛋白質結晶化剤の種類に応じて上述したモノマー等を適宜選択することにより、透明な蛋白質結晶化剤を保持するポリマーゲルを得ることができる。   For example, when NaCl is held in a gel, the gel is preferably prepared from acrylamide, 2-acrylamido-2-methylpropanesulfonic acid, and dimethylaminomethyl chloride methacrylate. In addition, a polymer gel holding a transparent protein crystallization agent can be obtained by appropriately selecting the above-described monomers and the like according to the type of the protein crystallization agent.

上述のように調製された蛋白質結晶化剤を保持するポリマーゲルに、蛋白質含有試料をアプライする。蛋白質含有試料のアプライは、任意の手法により行うことができ、例えば、蛋白質結晶化剤を保持するポリマーゲルに蛋白質含有試料を滴下したり、シリンジなどで手動若しくは機械的に充満させたり、又はポリマーゲルを蛋白質含有試料中に浸漬することなどにより蛋白質含有試料をアプライする。アプライする蛋白質含有試料の量は、蛋白質の結晶化条件などを考慮して設定する。   A protein-containing sample is applied to the polymer gel holding the protein crystallizing agent prepared as described above. The application of the protein-containing sample can be performed by any method. For example, the protein-containing sample is dropped on a polymer gel holding a protein crystallization agent, manually or mechanically filled with a syringe, or the polymer The protein-containing sample is applied by immersing the gel in the protein-containing sample. The amount of the protein-containing sample to be applied is set in consideration of protein crystallization conditions and the like.

次に工程(b)において、使用される油相としては、蛋白質に変性などの影響を及ぼさずに、水と分層するものであれば使用可能である。例えば流動パラフィンが使用される。前記油相は結晶化させる蛋白質の種類、及び分配係数等を考慮し適宜選択される。   Next, in the step (b), any oil phase may be used as long as it can be separated from water without affecting the protein such as denaturation. For example, liquid paraffin is used. The oil phase is appropriately selected in consideration of the type of protein to be crystallized and the partition coefficient.

この油相は蛋白質含有溶液の液面に重層するように供する。その量は適宜選択される。   This oil phase is provided so as to be overlaid on the liquid surface of the protein-containing solution. The amount is appropriately selected.

上述のように、蛋白質含有試料を、蛋白質結晶化剤を保持するポリマーゲルにアプライした後、さらに油相を蛋白質含有溶液の液面に重層することにより、蛋白質と蛋白質結晶化剤とが接触し、さらに蛋白質溶液が徐序に濃縮されることにより結晶化が進行する。本蛋白質結晶化方法においては、蛋白質結晶化剤がゲル中から蛋白質含有試料の部分に、又は蛋白質含有試料が蛋白質結晶化剤を保持するゲル中に、ゆっくりと移行し、結晶化反応も少しずつ起こる。それと同時に油相に水分が移行し、蛋白質溶液が徐序に濃縮される。この2つの効果により、結晶化のメカニズムである、蛋白質と周囲環境(蛋白質結晶化剤の存在、蛋白質濃度、pH等)との相互作用が徐々に2方向から進行するため、良質な結晶が析出することになる。   As described above, after the protein-containing sample is applied to the polymer gel holding the protein crystallization agent, the protein and the protein crystallization agent are brought into contact with each other by overlaying the oil phase on the liquid surface of the protein-containing solution. Furthermore, crystallization proceeds as the protein solution is gradually concentrated. In this protein crystallization method, the protein crystallization agent slowly moves from the gel to the portion of the protein-containing sample, or the protein-containing sample slowly moves into the gel holding the protein crystallization agent, and the crystallization reaction is gradually performed. Occur. At the same time, water moves to the oil phase and the protein solution is gradually concentrated. Because of these two effects, the interaction between the protein and the surrounding environment (presence of protein crystallization agent, protein concentration, pH, etc.), which is the mechanism of crystallization, gradually proceeds from two directions, so that high-quality crystals are precipitated. Will do.

蛋白質含有試料をアプライした後は、蛋白質が析出するのに十分な時間にわたって、適切な温度条件下にて、ポリマーゲルを密閉状態又は大気中に静置する。   After applying the protein-containing sample, the polymer gel is allowed to stand in an airtight state or in the atmosphere under an appropriate temperature condition for a time sufficient for the protein to precipitate.

蛋白質が析出するのに十分な時間とは、特定の蛋白質、濃度、結晶化条件などにより異なるが、約1時間〜10日である。また適切な温度条件もまた特定の蛋白質、濃度、結晶化条件などにより異なるが、約4℃〜30℃である。   The time sufficient for the protein to precipitate is approximately 1 hour to 10 days, although it varies depending on the specific protein, concentration, crystallization conditions, and the like. Appropriate temperature conditions also vary depending on the specific protein, concentration, crystallization conditions, etc., but are about 4 ° C. to 30 ° C.

そして蛋白質が析出するのに十分な時間が経過した後、蛋白質の結晶析出状況を、例えば光学顕微鏡、X線回折装置などにより観察する。本蛋白質結晶化方法においては、ポリマーゲルにおける蛋白質の結晶化をモニタリングするための公知のシステムを組み合わせて用いることができる。例えば、結晶析出の様子を、顕微鏡に搭載したCCDカメラにより撮影記録し、画像処理することによって、結晶化の成否を高速に判断することが可能である。   After a sufficient time has elapsed for the protein to precipitate, the state of protein crystal precipitation is observed, for example, with an optical microscope, an X-ray diffractometer or the like. In this protein crystallization method, a known system for monitoring protein crystallization in a polymer gel can be used in combination. For example, it is possible to determine the success or failure of crystallization at high speed by photographing and recording the state of crystal precipitation with a CCD camera mounted on a microscope and performing image processing.

以上のように、本蛋白質結晶化方法は、蛋白質含有試料と蛋白質結晶化剤とを、ゲル中の拡散を利用して徐々に接触・反応させて、蛋白質を結晶化させる。従って、本発明では、単に蛋白質含有試料をアプライする操作のみでX線解析などに適した良好な品質の蛋白質結晶を得ることができる。


As described above, in the present protein crystallization method, a protein-containing sample and a protein crystallization agent are gradually contacted and reacted using diffusion in the gel to crystallize the protein. Therefore, in the present invention, protein crystals of good quality suitable for X-ray analysis can be obtained by simply applying a protein-containing sample.


Claims (1)

蛋白質を結晶化させるための方法において、以下の工程を含むことを特徴とする蛋白質結晶化方法。
(a) 蛋白質含有試料を、蛋白質結晶化剤を保持するゲルポリマーに供し、前記蛋白質溶液と結晶化剤を接触させる工程。
(b) さらに蛋白質含有試料に油相を重層する工程。
A method for crystallizing a protein, comprising the following steps.
(a) A step of subjecting the protein-containing sample to a gel polymer holding a protein crystallization agent and bringing the protein solution into contact with the crystallization agent.
(b) A step of overlaying an oil phase on the protein-containing sample.
JP2004033095A 2004-02-10 2004-02-10 Method for crystallizing protein Pending JP2005224653A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2004033095A JP2005224653A (en) 2004-02-10 2004-02-10 Method for crystallizing protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004033095A JP2005224653A (en) 2004-02-10 2004-02-10 Method for crystallizing protein

Publications (1)

Publication Number Publication Date
JP2005224653A true JP2005224653A (en) 2005-08-25

Family

ID=34999787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004033095A Pending JP2005224653A (en) 2004-02-10 2004-02-10 Method for crystallizing protein

Country Status (1)

Country Link
JP (1) JP2005224653A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011013857A1 (en) * 2009-07-31 2011-02-03 株式会社コンポン研究所 Method for production of accumulated product of nano-substance, accumulated product of nano-substance, device comprising the accumulated product, and method for analysis of structure of nano-substance

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011013857A1 (en) * 2009-07-31 2011-02-03 株式会社コンポン研究所 Method for production of accumulated product of nano-substance, accumulated product of nano-substance, device comprising the accumulated product, and method for analysis of structure of nano-substance
JP2011031333A (en) * 2009-07-31 2011-02-17 Toyota Motor Corp Method for producing accumulated product of nano-substance, accumulated product of nano-substance, device comprising the accumulated product, and method for analyzing structure of nano-substance
US9109297B2 (en) 2009-07-31 2015-08-18 Genesis Research Institute, Incorporated Method for production of accumulated product of nano-substance, accumulated product of nano-substance, device comprising the accumulated product, and method for analysis of structure of nano-substance

Similar Documents

Publication Publication Date Title
US4833233A (en) Human serum albumin crystals and method of preparation
Zeppezauer [24] Formation of large crystals
JP5981133B2 (en) Temperature-responsive adsorbent having strong cation exchange group and method for producing the same
Saridakis et al. Imprinted polymers assisting protein crystallization
US5003047A (en) Method for purifying biologically active ligate
JP2007504215A (en) Method and apparatus for rapidly crystallizing biomolecules
US20050075482A1 (en) Array for crystallizing protein, device for crystallizing protein and method of screening protein crystallization using the same
JP2005224653A (en) Method for crystallizing protein
JP5999629B2 (en) Protein crystal production method
JPH07318551A (en) Chromatography and filler therefor
EP0955542A1 (en) Method for separating pth amino acids
Sugahara A technique for high-throughput protein crystallization in ionically cross-linked polysaccharide gel beads for x-ray diffraction experiments
Di Profio et al. Preparation of enzyme crystals with tunable morphology in membrane crystallizers
JP2007045668A (en) Method for crystallizing protein, peptide, amino acid, nucleic acid or water-soluble macromolecule
US9382639B2 (en) Device and method for crystallizing inorganic or organic substances
US20120135442A1 (en) Protein crystallization using molecularly imprinted polymers
Fenalti et al. Fluorescence recovery after photobleaching in Lipidic Cubic Phase (LCP-FRAP): a precrystallization assay for membrane proteins
JP2022107592A (en) Microfluidic chip for molecule crystallization, preparation method, device comprising the chip, and molecule crystallization method
CN112004875B (en) Method for depositing nano objects on the surface of a uniformly rigid polymer gel
JP2002262867A (en) Method for producing protein by cell-free protein synthetic system
CA2348054A1 (en) Processes and means for the isolation and purification of nucleic acids at surfaces
JP2009172530A (en) Method for recovering crystal
JP2011195636A (en) Method for producing porous membrane with affinity mechanism and method for separation and purification of protein
Trinh et al. Impact of double cryogelation process on a macroporous dye‐affinity hydrogel
Smatanová Crystallization of biological macromolecules